29 Biotech stocks on the move after news Posted by Jessica

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

29 Biotech stocks on the move after news

Posted by on Jan 09, 2013

The BioEnterprise Midwest Healthcare Venture Investment report revealed that healthcare technology companies in Ohio attracted $292 million in 2012, scoring a 65 percent growth from 2011, when $178 million was invested.

By sector, 2012 equity funding in the Midwest was to be paid to biopharmaceutical companies ($487 million), medical device companies ($309 million) and healthcare IT and service companies ($177 million).

In corporate news, Cell Therapeutics Inc (NASDAQ:CTIC) led biotech gainers on Tuesday after it launched clinical trial sites and started enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib.

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) skyrocketed after a report claimed the company is testing new drugs to defeat hypoxia in tumors.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) got a boost yesterday after President and CEO Jack Lief said the company is seeking partners to sell its weight-loss drug Belviq abroad once it clears regulatory hurdles.

Celgene Corporation (NASDAQ:CELG) jumped to new high on 2013 financial forecast and preliminary 2012 results.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) surged 5.60% a day after it announced completion of enrollment in Phase IIa hepatitis C trial.

Incyte Corporation (NASDAQ:INCY) advanced after its presentation at the JPMorgan Healthcare Conference revealed plans to focus on getting physicians to prescribe Jakafi earlier in the disease progression process and that it seeks more support about just how safe and effective the drug is.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) added 5% after providing its full-year 2013 strategic outlook and financial guidance.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) increased 4% after a report that the company is teaming up with the U.K. National Cancer Research Institute for a phase 3 trial, named SPIRIT, to assess the impact of switching chronic myeloid leukemia patients treated with a first-line tyrosine kinase inhibitor to Ponatinib.

Illumina, Inc. (NASDAQ:ILMN) gained $1.5 after declaring a series of product and technology innovations for its powerful sequencing ecosystem.

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) was up after David Meeker , M.D., President and Chief Executive Officer of Genzyme, a Sanofi Company, was elected to Savient’s Board of Directors, effective January 7, 2013.

Gilead Sciences, Inc. (NASDAQ:GILD) hit new 52-week high after signing antibody development deal with MacroGenics.

Some other positive hot stocks in the biotechnology industry were Biosante Pharmaceuticals Inc (NASDAQ:BPAX), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR), MannKind Corporation (NASDAQ:MNKD) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

On the flip side, Neostem Inc. (NYSEAMEX:NBS) was among the biggest losers following an announcement that Hackensack University Medical Center renewed its engagement of Progenitor Cell Therapy’s services for processing and storage of a variety of cell types used therapeutically by the hospital.

NuPathe Inc (NASDAQ ATH) turned red on Tuesday.

Dendreon Corporation (NASDAQ NDN) continued to decline after announcing preliminary fourth quarter 2012 revenues.

Sequenom, Inc. (NASDAQ:SQNM) was down after Illumina acquired rival.

Peregrine Pharmaceuticals (NASDAQ PHM) retreated after earningforecast issued consensus earnings forecast report on the company.

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) plunged after predicting net loss bewteen $115 Mln and $125 Mln for 2013.

VIVUS, Inc. (NASDAQ:VVUS) was down after unusual trading activity was linked to a possible insider trade.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) lost $5.9 after reporting lower-than-expected sales for its eye drug Eylea.

Complete Genomics, Inc. (NASDAQ:GNOM) decreased after rumors that Illumina (NASDAQ:ILMN) has withdrawn its bid to takeover GNOM.

Biogen Idec Inc. (NASDAQ:BIIB) edged down yesterday as it needs strong BG-12 launch to maintain momentum.

More on the flip side included Rexahn Pharmaceuticals, Inc. (NYSEAMEX:RNN), Hemispherx BioPharma, Inc (NYSEAMEX:HEB), Amgen, Inc. (NASDAQ:AMGN) and Celsion Corporation (NASDAQ:CLSN).

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Updated Category News Views 2

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 3

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Bybit Enhances BTC Staking Yields Amid Crypto Fluctuations

Updated Category News Views 2

An Uptick in BTC Staking Yields Seems like Bybit's got a trick up their sleeve with their latest move. They've hiked BTC staking yields from a static 0.8% up to a more attractive 1.2%. Now, if you're parked with Bitcoin in this dicey market, that's a substantial 50% leap upwards. When you think about those dreamy numbers traders like me fantasize about, it’s a juicy...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
Sotheby's to Auction Largest Flawless Paraiba Tourmalines

Updated Category News Views 1

Jaw-Dropping Gemstones Poised for Auction Glory The art of gemology isn't just about shiny rocks; it's a concoction of beauty, rarity, and, most importantly, value. And when the world's finest stones hit the auction block, it's akin to an epic performance in a long-awaited drama. On September 17, 2026, these precious Paraiba Tourmalines, fashioned by the adept hands of...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 1

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Vobile Teams Up with UNN for AI Factories in Brunei

Updated Category News Views 3

Delving into Vobile's Latest Strategic Move Vobile, a heavyweight in digital content protection based out of Santa Clara, California, has hit the headlines with a new venture. They've inked a strategic cooperation and commercial agreements with Unified National Networks (UNN) of Brunei Darussalam to construct AI factories. This ain't your run-of-the-mill news, folks. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

NCC Group plc's Strategic Dealings and Key Information Overview

Updated Category News Views 227

Key Information on NCC Group plc's Recent Trading Activities FORM 8.5 (EPT/RI) Public Dealing Disclosure by an Exempt Principal Trader This disclosure relates to the activities of Investec Bank plc, acting in the capacity of a recognized intermediary for NCC Group plc. Important Details for Investors 1. Key Information (a) Name of exempt principal trader: Investec Bank plc

Continue Reading
CLOUDSUFI Broadens AI Reach with Mexico Expansion

Updated Category News Views 6

AI Investment Shifts to Mexico In a world racing for AI dominance, there's no snooze button for competitive advantage. CLOUDSUFI's latest move? Dropping a new AI factory in Guadalajara, Mexico. This city isn't just another notch on the map—it's a tech hub packed with engineering prowess, robust US ties, and sitting neatly in the same time zones as North America. Talk...

Continue Reading
Piedmont Lithium Sees Changes Amid Market Trends and Evaluations

Updated Category News Views 193

BMO Capital's Perspective on Piedmont Lithium's Market Standing Piedmont Lithium (NASDAQ:PLL) has drawn considerable attention from analysts, especially BMO Capital, which has retained its Market Perform rating for the stock and set a consistent price target of $8.50. This decision follows a noteworthy visit to the North American Lithium (NAL) operations, where BMO...

Continue Reading
Important Update for Holdco Nuvo Group D.G Ltd. Investors

Updated Category News Views 75

Important Update for Holdco Nuvo Group D.G Ltd. Investors Attention all stakeholders of Holdco Nuvo Group D.G Ltd. A significant update has surfaced regarding the company's equity interests. A recent court order has imposed crucial restrictions on trading activities associated with Holdco Nuvo Group D.G Ltd. This situation is important for both direct and indirect holders...

Continue Reading
Urbanfund Corp. Q2 2024 Financial Results Overview

Updated Category News Views 170

Overview of Urbanfund Corp.'s Q2 2024 Financial Results Mitchell Cohen, the Chief Executive Officer and President of Urbanfund Corp. (TSX-V: UFC), has announced the filing of the Company’s financial statements for the three and six months ending June 30, 2024. This filing includes the Consolidated Financial Statements along with the Management's Discussion and Analysis...

Continue Reading